Fibroblast-specific adipocyte enhancer binding protein 1 is a potential pathological trigger and prognostic marker for liver fibrosis independent of etiology.

our current study confirmed high expression of AEBP1 was specifically associated with liver fibrosis and predicted its poor prognosis and the role of AEBP1 in HSCs, providing a new insight for understanding AEBP1 in liver fibrosis. This article is protected by copyright. All rights reserved.